Guest guest Posted September 20, 2010 Report Share Posted September 20, 2010 basicly, mold and possably bacterias, so closely related to our own cells, that it's confuseing our body to where it not only attacks the invaders but our own " SELF " causeing autoimmune disease. but once again, the deturmination to put it all on self and not on environment as the causeing factor. as always. this is why I dont like genetics being brought into this. science well forever ignore environmental toxin exposure if they can blame genetics instead. ---------------- molecular mimicry describes the theory that microbial pathogens share pieces of antigenic components with those of their hosts and when the host immune system attacks these pathogens it does collateral damage to the host. Molecular mimicry is thought to play an important role in triggering certain autoimmune diseases. Paradoxically, infections are known to reduce the overall incidence of certain allergies and autoimmune diseases. http://www.discoverymedicine.com/-Yang/2009/07/25/editors-note-june-2005\ / --------- MOLECULAR MIMICRY http://en.wikipedia.org/wiki/Molecular_mimicry HLA, molecular mimicry and multiple sclerosis. Liblau R, Gautam AM. Institut National de la Santé et de la Recherche Médicale, Pitie-Salpetriere Hospital, Paris, France. Abstract Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system in which an autoimmune response most probably contributes to pathogenesis. To date, the best characterized susceptibility-associated gene has been mapped to the HLA complex. The HLA-DRB1*1501 - DRB5*0101 - DQA1*0102 - DQB1*0602 haplotype is both associated and linked to MS in different ethnic groups. The locus within the HLA class II region encoding the MS-susceptibility gene is under intensive investigation. Epidemiological studies, however, have suggested that environmental antigens also play a critical role in MS pathogenesis. One of the ways a pathogen could trigger autoimmune disease is via immunological cross-reactivity or molecular mimicry. This concept argues that a microbial peptide with certain degree of homology to a self peptide can stimulate pathogenic self-reactive specific T cells to cause an autoimmune disease. Many microbial agents have regions of sequences that may serve as binding motifs for HLA-DR2. HLA genetics and molecular mimicry may therefore be intimately interlinked in the disease process. In the present review, we focus on the HLA association with MS and the role of microbial antigens in MS, with special reference to the molecular mimicry hypothesis. PMID: 11324698 [PubMed - indexed for MEDLINE] http://www.ncbi.nlm.nih.gov/pubmed/11324698?dopt=Abstract ------------ Molecular Mimicry/MS http://www.mult-sclerosis.org/MolecularMimicry.html --- J Immunol. 2009 Sep 1;183(5):3531-41. Epub 2009 Jul 31. HLA-DQB1*0602 determines disease susceptibility in a new " humanized " multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice. Kaushansky N, Altmann DM, Ascough S, CS, Lassmann H, Ben-Nun A. Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel. Abstract The susceptibility to multiple sclerosis (MS), a chronic neurological autoimmune disease that primarily targets CNS myelin, has long been associated with HLA class-II genes. Although several other HLA and non-HLA disease predisposing alleles have been identified, alleles of the HLA-DR15 haplotype (DRB1*1501, DRB5*0101, and DQB1*0602) remain the strongest susceptibility factor. Many studies have suggested that the HLA-DRB1*1501 allele determines MS-associated susceptibility. However, due to strong linkage disequilibrium within the HLA class II region, it has been difficult to unequivocally determine the relative roles of the DRB1*1501 and DQB1*0602 products. In this study we use HLA class-II transgenic mice to illuminate the relative contributions of the DRB1*1501 and DQB1*0602 alleles or their combination to susceptibility toward a new " humanized " MS-like disease induced by myelin-associated oligodendrocytic basic protein (MOBP). Although many immunological studies have focused overwhelmingly on the role of the HLA-DRB1*1501 product in MS, we show that HLA-DRB1*1501 transgenics are refractory to MOBP disease induction, whereas the HLA-DQB1*0602 transgenics are susceptible via T cells reactive against MOBP15-36 and MOBP55-77 encephalitogenic epitopes. Although both transgenics react against these epitopes, the MOBP15-36- and MOBP55-77-reactive T cells are of Th2-type in HLA-DRB1*1501 transgenics and are pathogenic Th1/Th17 cells in the HLA-DQB1*0602 transgenic mice. This new humanized model of MS further implicates autoimmunity against MOBP in MS pathogenesis, provides the first evidence of pathogenic HLA-DQ-associated anti-myelin autoimmunity, and is the first to offer a rationale for HLA-DQB1*0602 association with MS. These findings have important bearing on the candidacy of the DQB1*0602 allele as a genetic risk factor for MS. http://www.ncbi.nlm.nih.gov/pubmed/19648275 ---------- Autoimmun Rev. 2010 Feb;9(4):233-6. Epub 2009 Aug 13. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A. Department of Immunology, The Weizmann Institute of Science, P.O. Box 26, Rehovot 76000, Israel. Abstract Multiple sclerosis (MS) is a disease of the human CNS, characterized by perivascular inflammation, demyelination and axonal damage. Although the etiology of MS is unknown, it is believed that the disease results from destructive autoimmune mechanisms, presumably initiated by abnormal activation of potentially pathogenic autoimmune T-cells recognizing CNS components. The myelin-associated oligodendrocyte basic protein (MOBP), a relatively abundant CNS-specific myelin protein, which plays a role in stabilizing the myelin sheath in the CNS, has recently been implicated in the pathogenesis of MS. Here we review studies showing that MOBP is as an important candidate target antigen in MS as the other widely studied target antigens, myelin basic protein (MBP), proteolipid protein (PLP), and myelin oligodendrocyte glycoprotein (MOG). The studies summarized below indicate that T-cell autoimmunity against MOBP can be detected in MS patients; T-cells reactive against MOBP can be pathogenic in several mouse strains as well as in the " humanized " HLA-DR15-Tg mice; and, that the HLA-DQ6-restricted, but not HLA-DR15-restricted, MOBP-reactive T-cells cause in HLA-DR15-Tg mice MS-like clinical disease associated with perivascular and parenchymal infiltration, demyelination, axonal loss, and optic neuritis. Accordingly, the MOBP should be considered a bona fide primary target antigen in MS, in addition to MBP, PLP, and MOG. http://www.ncbi.nlm.nih.gov/pubmed/19683076 ---- J Autoimmun. 2001 May;16(3):293-302. Structural basis of molecular mimicry. Wucherpfennig KW. Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA. wucherpf@... Abstract Infectious agents are thought to play an important role in the development of autoimmune diseases. Sequence similarity between infectious agents and self-proteins (molecular mimicry) has been proposed as a mechanism for the induction of autoimmunity [1]. However, it has been difficult to identify microbial peptides that activate autoreactive T cells using conventional sequence alignments. This chapter reviews progress made in the identification of such microbial peptides based on the analysis of structural features that are important for TCR recognition of MHC-bound peptides [2]. http://www.ncbi.nlm.nih.gov/pubmed/11334495?dopt=Abstract Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.